Beijing Lepu Pharmaceutical Technology

Beijing Lepu Pharmaceutical Technology is a core subsidiary of Lepu Medical, focusing on the research, development, and manufacturing of pharmaceutical products. The company maintains a dual focus on cardiovascular health and oncology, leveraging its parent company's extensive distribution network in China. Its portfolio includes high-volume generic drugs for chronic conditions like hypertension and hyperlipidemia, as well as an expanding pipeline of innovative biologics, including PD-1 inhibitors and bispecific antibodies. Lepu Pharmaceutical operates several GMP-certified manufacturing facilities and is increasingly active in the global licensing and clinical development of its oncology assets.